Aspira Women's Health Inc.
AWHL· OTC
Released Aug 14, 2013, after the close
10-Q filed Aug 14, 2013, 45 days after period end · 0000926617-13-000011
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $323.00K | $321.00K | $304.00K | $344.00K |
| Net Income | -$2.12M | -$1.97M | -$5.71M | -$698.00K |
| EPS Diluted | -$0.11 |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.13 |
| -$0.39 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.